Ajanta Pharma posts Q4 and FY 2016 results
Revenue from operations grew 14 per cent at Rs 426 crores against Rs 372 crores in Q4 FY 2016
Author
Silicon India recognises pharma and life sciences solution providers
Companies were judged on industry solutions, innovation, client satisfaction and overall company performance
Delhi HC refrains from staying single judge interim order over breast cancer drug by Biocon and…
The division bench of the high court, however, said the drug-makers may continue to sell their products under the brand names
Anurag Roy joins DSM Sinochem Pharma as new Business Unit Director Asia Pacific, Middle East and…
His areas of expertise encompass driving business, strategic marketing, M&As etc
CII, IPO organise National Intellectual Property (IP) Awards: 2016
Recognises the use of IPRs as a strategic tool in commerce and industry
The Regional Centre for Biotechnology Bill, 2016 passed in Lok Sabha
The bill seeks to establish a regional centre for biotechnology, an institution of education, training and research, under UNESCO…
Syngene delivers sustained growth in Q4 FY16
Revenue grows 31 per cent to Rs 334 crore; EBITA up by 23 per cent to Rs 106 crore
OPPI with NLSU organises panel discussion to mark World IP Day
Discussions were held on how a good policy environment can reward innovation and protect intellectual property rights
ICMR, MoHFW, Govt. of Madhya Pradesh and Sun Pharma in agreement for Malaria Free India
Partnership to demonstrate malaria elimination in over 1,200 villages of MP's Mandla district by FY21
Recalling stocks to re-label drugs with revised prices not mandatory: NPPA
NPPA's April 13 OM shifts onus of implementing revised prices to trade: DG Shah, IPA